GRGDSPK is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.
CAT No: R1401
CAS No:111119-28-9
Synonyms/Alias:Grgdspk;111119-28-9;Gly-arg-gly-asp-ser-pro-lys;Glycyl-arginyl-glycyl-aspartyl-seryl-prolyl-lysine;CHEMBL58763;(2S)-6-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid;DTXSID20149506;EMD 56574;N2-(1-(N-(N-(N-(N2-Glycyl-L-arginyl)glycyl)-L-alpha-aspartyl)-L-seryl)-L-prolyl)-L-lysine;L-Lysine, N2-(1-(N-(N-(N-(N2-glycyl-L-arginyl)glycyl)-L-alpha-aspartyl)-L-seryl)-L-prolyl)-;MFCD00076462;H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH;SCHEMBL891576;DTXCID7071997;ZRVZOBGMZWVJOS-VMXHOPILSA-N;HY-P0322;BDBM50079446;NCGC00167196-01;DA-74135;FG109749;MS-31214;G12230;Gly-Arg-Gly-Asp-Ser-Pro-Lys, >=97% (HPLC);H-Gly-Arg-Gly-Asp-Ser-Pro-Lys-OH acetate salt;glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine;L-Lysine,glycyl-L-arginylglycyl-L-a-aspartyl-L-seryl-L-prolyl-;(S)-6-Amino-2-((S)-1-((6S,12S,15S)-1-amino-6-(2-aminoacetamido)-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oyl)pyrrolidine-2-carboxamido)hexanoic acid;(S)-6-amino-2-((S)-1-((6S,12S,15S)-1-amino-6-(2-aminoacetamido)-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecane)pyrrolidine-2-carboxamido)hexanoic acid;
GRGDSPK, also known as Gly-Arg-Gly-Asp-Ser-Pro-Lys, is a synthetic peptide widely recognized for its integrin-binding capabilities and its pivotal role in cell adhesion studies. As a linear peptide sequence derived from the fibronectin cell-binding domain, it contains the well-characterized RGD motif, which is instrumental in mediating interactions between cells and the extracellular matrix. The addition of serine, proline, and lysine residues enhances its solubility and bioactivity, making it a valuable tool for probing cellular signaling pathways, tissue engineering, and biomaterials research. Its defined structure and high specificity for integrin receptors have established it as a standard reagent in biochemical and biomedical investigations focused on cellular dynamics and matrix biology.
Cell Adhesion Assays: GRGDSPK is extensively employed in cell adhesion assays to investigate the mechanisms underlying integrin-mediated attachment. By coating culture surfaces or biomaterials with this peptide, researchers can selectively promote or inhibit the binding of cells expressing specific integrin subtypes, such as αvβ3 or α5β1. This targeted approach allows for detailed analysis of cell-matrix interactions, facilitating the study of adhesion-dependent signaling, cell spreading, and migration. Such assays are fundamental in elucidating how cells sense and respond to their microenvironment, with implications for developmental biology and cancer metastasis research.
Surface Functionalization: As a versatile surface modification agent, GRGDSPK is used to functionalize a variety of substrates, including polymers, hydrogels, and nanoparticles. Covalent or non-covalent attachment of the peptide to material surfaces enables precise control over cellular attachment and orientation. This functionalization strategy is particularly valuable in the design of bioactive scaffolds for tissue engineering, where guiding cell behavior is essential for successful tissue regeneration. The peptide's presence on engineered surfaces can enhance biocompatibility and promote the formation of organized cell layers, advancing the development of complex tissue constructs.
Cell Migration and Wound Healing Models: In vitro migration assays frequently utilize GRGDSPK to modulate integrin engagement and assess the migratory capacity of various cell types. By selectively activating or blocking integrin receptors, the peptide enables researchers to dissect the molecular pathways involved in cell motility and wound repair processes. Such studies provide insight into cytoskeletal dynamics, signal transduction, and the regulation of directional movement, which are critical for understanding tissue remodeling, angiogenesis, and pathological conditions like tumor invasion.
Signal Transduction Studies: The RGD motif within GRGDSPK serves as a robust tool for probing integrin-dependent signaling pathways. Upon binding to cell-surface integrins, the peptide can trigger intracellular cascades that regulate proliferation, survival, and differentiation. Researchers utilize it to dissect the downstream effects of integrin activation, including the recruitment of focal adhesion proteins and the modulation of kinase activity. These investigations are essential for mapping the complex networks that orchestrate cellular responses to extracellular cues, supporting advancements in both basic and applied biosciences.
Biomaterials Evaluation: GRGDSPK is routinely incorporated into the evaluation of novel biomaterials intended for biomedical applications. Its integrin-binding properties make it an ideal probe for assessing the bioactivity and cytocompatibility of new materials. By monitoring cell attachment, spreading, and viability on peptide-modified surfaces, scientists can optimize material formulations for improved performance in tissue engineering, implant design, and regenerative medicine research. The peptide's defined sequence and reproducible activity contribute to standardized testing protocols, ensuring reliable comparisons across different material platforms.
2. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.